nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—OPRD1—coronary artery disease	0.348	1	CbGaD
Hydromorphone—PTGS1—Acetylsalicylic acid—coronary artery disease	0.0275	0.073	CbGbCtD
Hydromorphone—CYP2C9—Fenofibrate—coronary artery disease	0.0255	0.0675	CbGbCtD
Hydromorphone—CYP2C9—Gemfibrozil—coronary artery disease	0.0204	0.0539	CbGbCtD
Hydromorphone—CYP2C9—Clopidogrel—coronary artery disease	0.0176	0.0468	CbGbCtD
Hydromorphone—CYP3A4—Ticagrelor—coronary artery disease	0.0166	0.044	CbGbCtD
Hydromorphone—CYP2C9—Pitavastatin—coronary artery disease	0.0154	0.0409	CbGbCtD
Hydromorphone—CYP2C9—Valsartan—coronary artery disease	0.015	0.0398	CbGbCtD
Hydromorphone—CYP3A4—Fenofibrate—coronary artery disease	0.0148	0.0392	CbGbCtD
Hydromorphone—CYP2D6—Niacin—coronary artery disease	0.0122	0.0324	CbGbCtD
Hydromorphone—CYP3A4—Gemfibrozil—coronary artery disease	0.0118	0.0314	CbGbCtD
Hydromorphone—CYP2C9—Rosuvastatin—coronary artery disease	0.0114	0.0301	CbGbCtD
Hydromorphone—CYP2D6—Timolol—coronary artery disease	0.0114	0.0301	CbGbCtD
Hydromorphone—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0111	0.0294	CbGbCtD
Hydromorphone—CYP2C9—Simvastatin—coronary artery disease	0.0106	0.028	CbGbCtD
Hydromorphone—CYP2C9—Lovastatin—coronary artery disease	0.0103	0.0274	CbGbCtD
Hydromorphone—CYP2C9—Pravastatin—coronary artery disease	0.0103	0.0274	CbGbCtD
Hydromorphone—CYP3A4—Clopidogrel—coronary artery disease	0.0103	0.0272	CbGbCtD
Hydromorphone—CYP2D6—Captopril—coronary artery disease	0.01	0.0265	CbGbCtD
Hydromorphone—CYP2D6—Simvastatin—coronary artery disease	0.00967	0.0256	CbGbCtD
Hydromorphone—CYP3A4—Eplerenone—coronary artery disease	0.00954	0.0253	CbGbCtD
Hydromorphone—CYP2D6—Lovastatin—coronary artery disease	0.00946	0.0251	CbGbCtD
Hydromorphone—CYP2D6—Pravastatin—coronary artery disease	0.00946	0.0251	CbGbCtD
Hydromorphone—CYP2C9—Atorvastatin—coronary artery disease	0.00942	0.025	CbGbCtD
Hydromorphone—CYP2C9—Losartan—coronary artery disease	0.00862	0.0228	CbGbCtD
Hydromorphone—CYP2D6—Atorvastatin—coronary artery disease	0.00862	0.0228	CbGbCtD
Hydromorphone—CYP3A4—Enalapril—coronary artery disease	0.0085	0.0225	CbGbCtD
Hydromorphone—CYP3A4—Ezetimibe—coronary artery disease	0.00661	0.0175	CbGbCtD
Hydromorphone—CYP3A4—Rosuvastatin—coronary artery disease	0.00661	0.0175	CbGbCtD
Hydromorphone—CYP3A4—Simvastatin—coronary artery disease	0.00615	0.0163	CbGbCtD
Hydromorphone—CYP3A4—Pravastatin—coronary artery disease	0.00602	0.0159	CbGbCtD
Hydromorphone—CYP3A4—Lovastatin—coronary artery disease	0.00602	0.0159	CbGbCtD
Hydromorphone—CYP3A4—Atorvastatin—coronary artery disease	0.00548	0.0145	CbGbCtD
Hydromorphone—CYP3A4—Losartan—coronary artery disease	0.00501	0.0133	CbGbCtD
Hydromorphone—Naloxone—CREB1—coronary artery disease	0.000649	0.146	CrCbGaD
Hydromorphone—Heroin—OPRD1—coronary artery disease	0.000523	0.117	CrCbGaD
Hydromorphone—Nalbuphine—OPRD1—coronary artery disease	0.000426	0.0958	CrCbGaD
Hydromorphone—Levorphanol—OPRD1—coronary artery disease	0.00041	0.0922	CrCbGaD
Hydromorphone—Oxymorphone—OPRD1—coronary artery disease	0.000347	0.0781	CrCbGaD
Hydromorphone—Naltrexone—OPRD1—coronary artery disease	0.000347	0.0781	CrCbGaD
Hydromorphone—Hydrocodone—OPRD1—coronary artery disease	0.000304	0.0682	CrCbGaD
Hydromorphone—Oxycodone—OPRD1—coronary artery disease	0.000277	0.0623	CrCbGaD
Hydromorphone—Codeine—OPRD1—coronary artery disease	0.000264	0.0594	CrCbGaD
Hydromorphone—Naloxone—OPRD1—coronary artery disease	0.000253	0.0569	CrCbGaD
Hydromorphone—Morphine—OPRD1—coronary artery disease	0.000214	0.0481	CrCbGaD
Hydromorphone—Dextromethorphan—OPRD1—coronary artery disease	0.00018	0.0404	CrCbGaD
Hydromorphone—CYP2C9—cardial valve—coronary artery disease	0.000129	0.558	CbGeAlD
Hydromorphone—Naloxone—ESR1—coronary artery disease	0.000126	0.0284	CrCbGaD
Hydromorphone—Dextromethorphan—CYP2C19—coronary artery disease	7.18e-05	0.0161	CrCbGaD
Hydromorphone—Naloxone—ALB—coronary artery disease	5.62e-05	0.0126	CrCbGaD
Hydromorphone—Confusional state—Ramipril—coronary artery disease	4.49e-05	0.000246	CcSEcCtD
Hydromorphone—Discomfort—Timolol—coronary artery disease	4.49e-05	0.000246	CcSEcCtD
Hydromorphone—Asthenia—Niacin—coronary artery disease	4.48e-05	0.000246	CcSEcCtD
Hydromorphone—Fatigue—Losartan—coronary artery disease	4.48e-05	0.000246	CcSEcCtD
Hydromorphone—Headache—Ezetimibe—coronary artery disease	4.47e-05	0.000245	CcSEcCtD
Hydromorphone—Malaise—Lisinopril—coronary artery disease	4.46e-05	0.000245	CcSEcCtD
Hydromorphone—Anaphylactic shock—Ramipril—coronary artery disease	4.45e-05	0.000244	CcSEcCtD
Hydromorphone—Vertigo—Lisinopril—coronary artery disease	4.45e-05	0.000244	CcSEcCtD
Hydromorphone—Dry mouth—Timolol—coronary artery disease	4.44e-05	0.000244	CcSEcCtD
Hydromorphone—Constipation—Losartan—coronary artery disease	4.44e-05	0.000244	CcSEcCtD
Hydromorphone—Pain—Losartan—coronary artery disease	4.44e-05	0.000244	CcSEcCtD
Hydromorphone—Syncope—Lisinopril—coronary artery disease	4.44e-05	0.000243	CcSEcCtD
Hydromorphone—Vomiting—Eplerenone—coronary artery disease	4.44e-05	0.000243	CcSEcCtD
Hydromorphone—Feeling abnormal—Furosemide—coronary artery disease	4.44e-05	0.000243	CcSEcCtD
Hydromorphone—Leukopenia—Lisinopril—coronary artery disease	4.43e-05	0.000243	CcSEcCtD
Hydromorphone—Nausea—Fenofibrate—coronary artery disease	4.42e-05	0.000243	CcSEcCtD
Hydromorphone—Pruritus—Niacin—coronary artery disease	4.42e-05	0.000242	CcSEcCtD
Hydromorphone—Asthenia—Pravastatin—coronary artery disease	4.41e-05	0.000242	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Furosemide—coronary artery disease	4.4e-05	0.000241	CcSEcCtD
Hydromorphone—Rash—Eplerenone—coronary artery disease	4.4e-05	0.000241	CcSEcCtD
Hydromorphone—Urticaria—Perindopril—coronary artery disease	4.4e-05	0.000241	CcSEcCtD
Hydromorphone—Hypersensitivity—Trandolapril—coronary artery disease	4.4e-05	0.000241	CcSEcCtD
Hydromorphone—Dermatitis—Eplerenone—coronary artery disease	4.4e-05	0.000241	CcSEcCtD
Hydromorphone—Diarrhoea—Valsartan—coronary artery disease	4.4e-05	0.000241	CcSEcCtD
Hydromorphone—Confusional state—Timolol—coronary artery disease	4.39e-05	0.000241	CcSEcCtD
Hydromorphone—Shock—Ramipril—coronary artery disease	4.38e-05	0.00024	CcSEcCtD
Hydromorphone—Hypersensitivity—Enalapril—coronary artery disease	4.38e-05	0.00024	CcSEcCtD
Hydromorphone—Abdominal pain—Perindopril—coronary artery disease	4.38e-05	0.00024	CcSEcCtD
Hydromorphone—Body temperature increased—Perindopril—coronary artery disease	4.38e-05	0.00024	CcSEcCtD
Hydromorphone—Palpitations—Lisinopril—coronary artery disease	4.37e-05	0.00024	CcSEcCtD
Hydromorphone—Diarrhoea—Olmesartan—coronary artery disease	4.37e-05	0.00024	CcSEcCtD
Hydromorphone—Headache—Eplerenone—coronary artery disease	4.37e-05	0.00024	CcSEcCtD
Hydromorphone—Nervous system disorder—Ramipril—coronary artery disease	4.37e-05	0.00024	CcSEcCtD
Hydromorphone—Anaphylactic shock—Timolol—coronary artery disease	4.35e-05	0.000239	CcSEcCtD
Hydromorphone—Pruritus—Pravastatin—coronary artery disease	4.35e-05	0.000239	CcSEcCtD
Hydromorphone—Loss of consciousness—Lisinopril—coronary artery disease	4.35e-05	0.000239	CcSEcCtD
Hydromorphone—Nausea—Clopidogrel—coronary artery disease	4.35e-05	0.000238	CcSEcCtD
Hydromorphone—Tachycardia—Ramipril—coronary artery disease	4.35e-05	0.000238	CcSEcCtD
Hydromorphone—Skin disorder—Ramipril—coronary artery disease	4.33e-05	0.000237	CcSEcCtD
Hydromorphone—Infection—Timolol—coronary artery disease	4.33e-05	0.000237	CcSEcCtD
Hydromorphone—Vomiting—Simvastatin—coronary artery disease	4.32e-05	0.000237	CcSEcCtD
Hydromorphone—Hypersensitivity—Telmisartan—coronary artery disease	4.32e-05	0.000237	CcSEcCtD
Hydromorphone—Cough—Lisinopril—coronary artery disease	4.32e-05	0.000237	CcSEcCtD
Hydromorphone—Nausea—Lovastatin—coronary artery disease	4.32e-05	0.000237	CcSEcCtD
Hydromorphone—Hyperhidrosis—Ramipril—coronary artery disease	4.31e-05	0.000236	CcSEcCtD
Hydromorphone—Rash—Simvastatin—coronary artery disease	4.29e-05	0.000235	CcSEcCtD
Hydromorphone—Dermatitis—Simvastatin—coronary artery disease	4.28e-05	0.000235	CcSEcCtD
Hydromorphone—Asthenia—Trandolapril—coronary artery disease	4.28e-05	0.000235	CcSEcCtD
Hydromorphone—Shock—Timolol—coronary artery disease	4.28e-05	0.000235	CcSEcCtD
Hydromorphone—Feeling abnormal—Losartan—coronary artery disease	4.28e-05	0.000235	CcSEcCtD
Hydromorphone—Urticaria—Furosemide—coronary artery disease	4.28e-05	0.000235	CcSEcCtD
Hydromorphone—Diarrhoea—Niacin—coronary artery disease	4.27e-05	0.000234	CcSEcCtD
Hydromorphone—Nervous system disorder—Timolol—coronary artery disease	4.27e-05	0.000234	CcSEcCtD
Hydromorphone—Asthenia—Enalapril—coronary artery disease	4.27e-05	0.000234	CcSEcCtD
Hydromorphone—Headache—Simvastatin—coronary artery disease	4.26e-05	0.000234	CcSEcCtD
Hydromorphone—Body temperature increased—Furosemide—coronary artery disease	4.26e-05	0.000233	CcSEcCtD
Hydromorphone—Abdominal pain—Furosemide—coronary artery disease	4.26e-05	0.000233	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Losartan—coronary artery disease	4.25e-05	0.000233	CcSEcCtD
Hydromorphone—Dizziness—Valsartan—coronary artery disease	4.25e-05	0.000233	CcSEcCtD
Hydromorphone—Anorexia—Ramipril—coronary artery disease	4.25e-05	0.000233	CcSEcCtD
Hydromorphone—Nausea—Ezetimibe—coronary artery disease	4.24e-05	0.000232	CcSEcCtD
Hydromorphone—Skin disorder—Timolol—coronary artery disease	4.23e-05	0.000232	CcSEcCtD
Hydromorphone—Dizziness—Olmesartan—coronary artery disease	4.23e-05	0.000232	CcSEcCtD
Hydromorphone—Pruritus—Trandolapril—coronary artery disease	4.23e-05	0.000232	CcSEcCtD
Hydromorphone—Arthralgia—Lisinopril—coronary artery disease	4.21e-05	0.000231	CcSEcCtD
Hydromorphone—Chest pain—Lisinopril—coronary artery disease	4.21e-05	0.000231	CcSEcCtD
Hydromorphone—Myalgia—Lisinopril—coronary artery disease	4.21e-05	0.000231	CcSEcCtD
Hydromorphone—Hyperhidrosis—Timolol—coronary artery disease	4.21e-05	0.000231	CcSEcCtD
Hydromorphone—Asthenia—Telmisartan—coronary artery disease	4.21e-05	0.000231	CcSEcCtD
Hydromorphone—Pruritus—Enalapril—coronary artery disease	4.21e-05	0.000231	CcSEcCtD
Hydromorphone—Diarrhoea—Pravastatin—coronary artery disease	4.21e-05	0.000231	CcSEcCtD
Hydromorphone—Anxiety—Lisinopril—coronary artery disease	4.2e-05	0.00023	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	4.19e-05	0.000229	CcSEcCtD
Hydromorphone—Discomfort—Lisinopril—coronary artery disease	4.16e-05	0.000228	CcSEcCtD
Hydromorphone—Hypotension—Ramipril—coronary artery disease	4.16e-05	0.000228	CcSEcCtD
Hydromorphone—Anorexia—Timolol—coronary artery disease	4.15e-05	0.000228	CcSEcCtD
Hydromorphone—Pruritus—Telmisartan—coronary artery disease	4.15e-05	0.000228	CcSEcCtD
Hydromorphone—Nausea—Eplerenone—coronary artery disease	4.15e-05	0.000227	CcSEcCtD
Hydromorphone—Dizziness—Niacin—coronary artery disease	4.13e-05	0.000226	CcSEcCtD
Hydromorphone—Urticaria—Losartan—coronary artery disease	4.13e-05	0.000226	CcSEcCtD
Hydromorphone—Dry mouth—Lisinopril—coronary artery disease	4.12e-05	0.000226	CcSEcCtD
Hydromorphone—Body temperature increased—Losartan—coronary artery disease	4.11e-05	0.000225	CcSEcCtD
Hydromorphone—Abdominal pain—Losartan—coronary artery disease	4.11e-05	0.000225	CcSEcCtD
Hydromorphone—Asthenia—Captopril—coronary artery disease	4.09e-05	0.000224	CcSEcCtD
Hydromorphone—Diarrhoea—Trandolapril—coronary artery disease	4.09e-05	0.000224	CcSEcCtD
Hydromorphone—Vomiting—Valsartan—coronary artery disease	4.08e-05	0.000224	CcSEcCtD
Hydromorphone—Confusional state—Lisinopril—coronary artery disease	4.07e-05	0.000223	CcSEcCtD
Hydromorphone—Diarrhoea—Enalapril—coronary artery disease	4.07e-05	0.000223	CcSEcCtD
Hydromorphone—Hypotension—Timolol—coronary artery disease	4.07e-05	0.000223	CcSEcCtD
Hydromorphone—Dizziness—Pravastatin—coronary artery disease	4.07e-05	0.000223	CcSEcCtD
Hydromorphone—Vomiting—Olmesartan—coronary artery disease	4.06e-05	0.000223	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.06e-05	0.000223	CcSEcCtD
Hydromorphone—Rash—Valsartan—coronary artery disease	4.05e-05	0.000222	CcSEcCtD
Hydromorphone—Dermatitis—Valsartan—coronary artery disease	4.05e-05	0.000222	CcSEcCtD
Hydromorphone—Nausea—Simvastatin—coronary artery disease	4.04e-05	0.000222	CcSEcCtD
Hydromorphone—Anaphylactic shock—Lisinopril—coronary artery disease	4.04e-05	0.000222	CcSEcCtD
Hydromorphone—Pruritus—Captopril—coronary artery disease	4.04e-05	0.000221	CcSEcCtD
Hydromorphone—Rash—Olmesartan—coronary artery disease	4.03e-05	0.000221	CcSEcCtD
Hydromorphone—Insomnia—Ramipril—coronary artery disease	4.03e-05	0.000221	CcSEcCtD
Hydromorphone—Dermatitis—Olmesartan—coronary artery disease	4.03e-05	0.000221	CcSEcCtD
Hydromorphone—Headache—Valsartan—coronary artery disease	4.02e-05	0.000221	CcSEcCtD
Hydromorphone—Diarrhoea—Telmisartan—coronary artery disease	4.01e-05	0.00022	CcSEcCtD
Hydromorphone—Infection—Lisinopril—coronary artery disease	4.01e-05	0.00022	CcSEcCtD
Hydromorphone—Headache—Olmesartan—coronary artery disease	4e-05	0.00022	CcSEcCtD
Hydromorphone—Paraesthesia—Ramipril—coronary artery disease	4e-05	0.000219	CcSEcCtD
Hydromorphone—Shock—Lisinopril—coronary artery disease	3.97e-05	0.000218	CcSEcCtD
Hydromorphone—Asthenia—Perindopril—coronary artery disease	3.97e-05	0.000218	CcSEcCtD
Hydromorphone—Dyspnoea—Ramipril—coronary artery disease	3.97e-05	0.000218	CcSEcCtD
Hydromorphone—Vomiting—Niacin—coronary artery disease	3.97e-05	0.000218	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Timolol—coronary artery disease	3.97e-05	0.000218	CcSEcCtD
Hydromorphone—Hypersensitivity—Furosemide—coronary artery disease	3.97e-05	0.000218	CcSEcCtD
Hydromorphone—Somnolence—Ramipril—coronary artery disease	3.96e-05	0.000217	CcSEcCtD
Hydromorphone—Dizziness—Trandolapril—coronary artery disease	3.95e-05	0.000217	CcSEcCtD
Hydromorphone—Tachycardia—Lisinopril—coronary artery disease	3.94e-05	0.000216	CcSEcCtD
Hydromorphone—Insomnia—Timolol—coronary artery disease	3.94e-05	0.000216	CcSEcCtD
Hydromorphone—Rash—Niacin—coronary artery disease	3.94e-05	0.000216	CcSEcCtD
Hydromorphone—Dermatitis—Niacin—coronary artery disease	3.93e-05	0.000216	CcSEcCtD
Hydromorphone—Dizziness—Enalapril—coronary artery disease	3.93e-05	0.000216	CcSEcCtD
Hydromorphone—Skin disorder—Lisinopril—coronary artery disease	3.92e-05	0.000215	CcSEcCtD
Hydromorphone—Dyspepsia—Ramipril—coronary artery disease	3.92e-05	0.000215	CcSEcCtD
Hydromorphone—Pruritus—Perindopril—coronary artery disease	3.92e-05	0.000215	CcSEcCtD
Hydromorphone—Headache—Niacin—coronary artery disease	3.91e-05	0.000215	CcSEcCtD
Hydromorphone—Paraesthesia—Timolol—coronary artery disease	3.91e-05	0.000214	CcSEcCtD
Hydromorphone—Vomiting—Pravastatin—coronary artery disease	3.91e-05	0.000214	CcSEcCtD
Hydromorphone—Hyperhidrosis—Lisinopril—coronary artery disease	3.91e-05	0.000214	CcSEcCtD
Hydromorphone—Diarrhoea—Captopril—coronary artery disease	3.9e-05	0.000214	CcSEcCtD
Hydromorphone—Dyspnoea—Timolol—coronary artery disease	3.88e-05	0.000213	CcSEcCtD
Hydromorphone—Dizziness—Telmisartan—coronary artery disease	3.88e-05	0.000213	CcSEcCtD
Hydromorphone—Rash—Pravastatin—coronary artery disease	3.88e-05	0.000213	CcSEcCtD
Hydromorphone—Dermatitis—Pravastatin—coronary artery disease	3.87e-05	0.000212	CcSEcCtD
Hydromorphone—Decreased appetite—Ramipril—coronary artery disease	3.87e-05	0.000212	CcSEcCtD
Hydromorphone—Somnolence—Timolol—coronary artery disease	3.87e-05	0.000212	CcSEcCtD
Hydromorphone—Asthenia—Furosemide—coronary artery disease	3.86e-05	0.000212	CcSEcCtD
Hydromorphone—Headache—Pravastatin—coronary artery disease	3.85e-05	0.000211	CcSEcCtD
Hydromorphone—Anorexia—Lisinopril—coronary artery disease	3.85e-05	0.000211	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Ramipril—coronary artery disease	3.85e-05	0.000211	CcSEcCtD
Hydromorphone—Fatigue—Ramipril—coronary artery disease	3.84e-05	0.000211	CcSEcCtD
Hydromorphone—Dyspepsia—Timolol—coronary artery disease	3.83e-05	0.00021	CcSEcCtD
Hydromorphone—Hypersensitivity—Losartan—coronary artery disease	3.83e-05	0.00021	CcSEcCtD
Hydromorphone—Nausea—Valsartan—coronary artery disease	3.82e-05	0.000209	CcSEcCtD
Hydromorphone—Pruritus—Furosemide—coronary artery disease	3.81e-05	0.000209	CcSEcCtD
Hydromorphone—Constipation—Ramipril—coronary artery disease	3.81e-05	0.000209	CcSEcCtD
Hydromorphone—Nausea—Olmesartan—coronary artery disease	3.8e-05	0.000208	CcSEcCtD
Hydromorphone—Vomiting—Trandolapril—coronary artery disease	3.8e-05	0.000208	CcSEcCtD
Hydromorphone—Diarrhoea—Perindopril—coronary artery disease	3.79e-05	0.000208	CcSEcCtD
Hydromorphone—Decreased appetite—Timolol—coronary artery disease	3.79e-05	0.000208	CcSEcCtD
Hydromorphone—Vomiting—Enalapril—coronary artery disease	3.78e-05	0.000207	CcSEcCtD
Hydromorphone—Hypotension—Lisinopril—coronary artery disease	3.78e-05	0.000207	CcSEcCtD
Hydromorphone—Dizziness—Captopril—coronary artery disease	3.77e-05	0.000207	CcSEcCtD
Hydromorphone—Rash—Trandolapril—coronary artery disease	3.77e-05	0.000206	CcSEcCtD
Hydromorphone—Dermatitis—Trandolapril—coronary artery disease	3.76e-05	0.000206	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Timolol—coronary artery disease	3.76e-05	0.000206	CcSEcCtD
Hydromorphone—Fatigue—Timolol—coronary artery disease	3.75e-05	0.000206	CcSEcCtD
Hydromorphone—Rash—Enalapril—coronary artery disease	3.75e-05	0.000206	CcSEcCtD
Hydromorphone—Dermatitis—Enalapril—coronary artery disease	3.75e-05	0.000205	CcSEcCtD
Hydromorphone—Headache—Trandolapril—coronary artery disease	3.74e-05	0.000205	CcSEcCtD
Hydromorphone—Vomiting—Telmisartan—coronary artery disease	3.73e-05	0.000205	CcSEcCtD
Hydromorphone—Asthenia—Losartan—coronary artery disease	3.73e-05	0.000204	CcSEcCtD
Hydromorphone—Headache—Enalapril—coronary artery disease	3.73e-05	0.000204	CcSEcCtD
Hydromorphone—Pain—Timolol—coronary artery disease	3.72e-05	0.000204	CcSEcCtD
Hydromorphone—Nausea—Niacin—coronary artery disease	3.71e-05	0.000203	CcSEcCtD
Hydromorphone—Rash—Telmisartan—coronary artery disease	3.7e-05	0.000203	CcSEcCtD
Hydromorphone—Dermatitis—Telmisartan—coronary artery disease	3.7e-05	0.000203	CcSEcCtD
Hydromorphone—Diarrhoea—Furosemide—coronary artery disease	3.68e-05	0.000202	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.68e-05	0.000202	CcSEcCtD
Hydromorphone—Pruritus—Losartan—coronary artery disease	3.68e-05	0.000202	CcSEcCtD
Hydromorphone—Headache—Telmisartan—coronary artery disease	3.68e-05	0.000202	CcSEcCtD
Hydromorphone—Feeling abnormal—Ramipril—coronary artery disease	3.67e-05	0.000201	CcSEcCtD
Hydromorphone—Dizziness—Perindopril—coronary artery disease	3.66e-05	0.000201	CcSEcCtD
Hydromorphone—Insomnia—Lisinopril—coronary artery disease	3.65e-05	0.0002	CcSEcCtD
Hydromorphone—Nausea—Pravastatin—coronary artery disease	3.65e-05	0.0002	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Ramipril—coronary artery disease	3.64e-05	0.0002	CcSEcCtD
Hydromorphone—Paraesthesia—Lisinopril—coronary artery disease	3.63e-05	0.000199	CcSEcCtD
Hydromorphone—Vomiting—Captopril—coronary artery disease	3.63e-05	0.000199	CcSEcCtD
Hydromorphone—Dyspnoea—Lisinopril—coronary artery disease	3.6e-05	0.000197	CcSEcCtD
Hydromorphone—Rash—Captopril—coronary artery disease	3.6e-05	0.000197	CcSEcCtD
Hydromorphone—Dermatitis—Captopril—coronary artery disease	3.59e-05	0.000197	CcSEcCtD
Hydromorphone—Somnolence—Lisinopril—coronary artery disease	3.59e-05	0.000197	CcSEcCtD
Hydromorphone—Feeling abnormal—Timolol—coronary artery disease	3.59e-05	0.000197	CcSEcCtD
Hydromorphone—Headache—Captopril—coronary artery disease	3.57e-05	0.000196	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Timolol—coronary artery disease	3.56e-05	0.000195	CcSEcCtD
Hydromorphone—Dizziness—Furosemide—coronary artery disease	3.56e-05	0.000195	CcSEcCtD
Hydromorphone—Dyspepsia—Lisinopril—coronary artery disease	3.56e-05	0.000195	CcSEcCtD
Hydromorphone—Diarrhoea—Losartan—coronary artery disease	3.55e-05	0.000195	CcSEcCtD
Hydromorphone—Nausea—Trandolapril—coronary artery disease	3.55e-05	0.000195	CcSEcCtD
Hydromorphone—Urticaria—Ramipril—coronary artery disease	3.54e-05	0.000194	CcSEcCtD
Hydromorphone—Nausea—Enalapril—coronary artery disease	3.53e-05	0.000194	CcSEcCtD
Hydromorphone—Vomiting—Perindopril—coronary artery disease	3.52e-05	0.000193	CcSEcCtD
Hydromorphone—Abdominal pain—Ramipril—coronary artery disease	3.52e-05	0.000193	CcSEcCtD
Hydromorphone—Body temperature increased—Ramipril—coronary artery disease	3.52e-05	0.000193	CcSEcCtD
Hydromorphone—Decreased appetite—Lisinopril—coronary artery disease	3.51e-05	0.000193	CcSEcCtD
Hydromorphone—Rash—Perindopril—coronary artery disease	3.49e-05	0.000191	CcSEcCtD
Hydromorphone—Dermatitis—Perindopril—coronary artery disease	3.49e-05	0.000191	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.49e-05	0.000191	CcSEcCtD
Hydromorphone—Nausea—Telmisartan—coronary artery disease	3.48e-05	0.000191	CcSEcCtD
Hydromorphone—Fatigue—Lisinopril—coronary artery disease	3.48e-05	0.000191	CcSEcCtD
Hydromorphone—Headache—Perindopril—coronary artery disease	3.47e-05	0.00019	CcSEcCtD
Hydromorphone—Urticaria—Timolol—coronary artery disease	3.46e-05	0.00019	CcSEcCtD
Hydromorphone—Pain—Lisinopril—coronary artery disease	3.45e-05	0.000189	CcSEcCtD
Hydromorphone—Constipation—Lisinopril—coronary artery disease	3.45e-05	0.000189	CcSEcCtD
Hydromorphone—Body temperature increased—Timolol—coronary artery disease	3.44e-05	0.000189	CcSEcCtD
Hydromorphone—Abdominal pain—Timolol—coronary artery disease	3.44e-05	0.000189	CcSEcCtD
Hydromorphone—Dizziness—Losartan—coronary artery disease	3.44e-05	0.000188	CcSEcCtD
Hydromorphone—Vomiting—Furosemide—coronary artery disease	3.42e-05	0.000188	CcSEcCtD
Hydromorphone—Rash—Furosemide—coronary artery disease	3.39e-05	0.000186	CcSEcCtD
Hydromorphone—Dermatitis—Furosemide—coronary artery disease	3.39e-05	0.000186	CcSEcCtD
Hydromorphone—Nausea—Captopril—coronary artery disease	3.39e-05	0.000186	CcSEcCtD
Hydromorphone—Headache—Furosemide—coronary artery disease	3.37e-05	0.000185	CcSEcCtD
Hydromorphone—Feeling abnormal—Lisinopril—coronary artery disease	3.33e-05	0.000183	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Lisinopril—coronary artery disease	3.3e-05	0.000181	CcSEcCtD
Hydromorphone—Vomiting—Losartan—coronary artery disease	3.3e-05	0.000181	CcSEcCtD
Hydromorphone—Nausea—Perindopril—coronary artery disease	3.29e-05	0.00018	CcSEcCtD
Hydromorphone—Hypersensitivity—Ramipril—coronary artery disease	3.28e-05	0.00018	CcSEcCtD
Hydromorphone—Rash—Losartan—coronary artery disease	3.28e-05	0.00018	CcSEcCtD
Hydromorphone—Dermatitis—Losartan—coronary artery disease	3.27e-05	0.000179	CcSEcCtD
Hydromorphone—Headache—Losartan—coronary artery disease	3.25e-05	0.000178	CcSEcCtD
Hydromorphone—Urticaria—Lisinopril—coronary artery disease	3.21e-05	0.000176	CcSEcCtD
Hydromorphone—Hypersensitivity—Timolol—coronary artery disease	3.21e-05	0.000176	CcSEcCtD
Hydromorphone—Nausea—Furosemide—coronary artery disease	3.2e-05	0.000175	CcSEcCtD
Hydromorphone—Asthenia—Ramipril—coronary artery disease	3.2e-05	0.000175	CcSEcCtD
Hydromorphone—Body temperature increased—Lisinopril—coronary artery disease	3.19e-05	0.000175	CcSEcCtD
Hydromorphone—Abdominal pain—Lisinopril—coronary artery disease	3.19e-05	0.000175	CcSEcCtD
Hydromorphone—Pruritus—Ramipril—coronary artery disease	3.15e-05	0.000173	CcSEcCtD
Hydromorphone—Asthenia—Timolol—coronary artery disease	3.12e-05	0.000171	CcSEcCtD
Hydromorphone—Nausea—Losartan—coronary artery disease	3.09e-05	0.000169	CcSEcCtD
Hydromorphone—Pruritus—Timolol—coronary artery disease	3.08e-05	0.000169	CcSEcCtD
Hydromorphone—Diarrhoea—Ramipril—coronary artery disease	3.05e-05	0.000167	CcSEcCtD
Hydromorphone—Diarrhoea—Timolol—coronary artery disease	2.98e-05	0.000163	CcSEcCtD
Hydromorphone—Hypersensitivity—Lisinopril—coronary artery disease	2.98e-05	0.000163	CcSEcCtD
Hydromorphone—Dizziness—Ramipril—coronary artery disease	2.95e-05	0.000162	CcSEcCtD
Hydromorphone—Asthenia—Lisinopril—coronary artery disease	2.9e-05	0.000159	CcSEcCtD
Hydromorphone—Dizziness—Timolol—coronary artery disease	2.88e-05	0.000158	CcSEcCtD
Hydromorphone—Pruritus—Lisinopril—coronary artery disease	2.86e-05	0.000157	CcSEcCtD
Hydromorphone—Vomiting—Ramipril—coronary artery disease	2.83e-05	0.000155	CcSEcCtD
Hydromorphone—Rash—Ramipril—coronary artery disease	2.81e-05	0.000154	CcSEcCtD
Hydromorphone—Dermatitis—Ramipril—coronary artery disease	2.81e-05	0.000154	CcSEcCtD
Hydromorphone—Headache—Ramipril—coronary artery disease	2.79e-05	0.000153	CcSEcCtD
Hydromorphone—Vomiting—Timolol—coronary artery disease	2.77e-05	0.000152	CcSEcCtD
Hydromorphone—Diarrhoea—Lisinopril—coronary artery disease	2.76e-05	0.000152	CcSEcCtD
Hydromorphone—Rash—Timolol—coronary artery disease	2.75e-05	0.000151	CcSEcCtD
Hydromorphone—Dermatitis—Timolol—coronary artery disease	2.74e-05	0.00015	CcSEcCtD
Hydromorphone—Headache—Timolol—coronary artery disease	2.73e-05	0.00015	CcSEcCtD
Hydromorphone—Dizziness—Lisinopril—coronary artery disease	2.67e-05	0.000146	CcSEcCtD
Hydromorphone—Nausea—Ramipril—coronary artery disease	2.65e-05	0.000145	CcSEcCtD
Hydromorphone—Nausea—Timolol—coronary artery disease	2.59e-05	0.000142	CcSEcCtD
Hydromorphone—Vomiting—Lisinopril—coronary artery disease	2.57e-05	0.000141	CcSEcCtD
Hydromorphone—Rash—Lisinopril—coronary artery disease	2.55e-05	0.00014	CcSEcCtD
Hydromorphone—Dermatitis—Lisinopril—coronary artery disease	2.54e-05	0.00014	CcSEcCtD
Hydromorphone—Headache—Lisinopril—coronary artery disease	2.53e-05	0.000139	CcSEcCtD
Hydromorphone—Nausea—Lisinopril—coronary artery disease	2.4e-05	0.000132	CcSEcCtD
Hydromorphone—PTGS1—artery—coronary artery disease	1.77e-05	0.0764	CbGeAlD
Hydromorphone—PTGS1—endothelium—coronary artery disease	1.5e-05	0.0646	CbGeAlD
Hydromorphone—OPRM1—blood—coronary artery disease	9.97e-06	0.0431	CbGeAlD
Hydromorphone—PTGS1—myocardium—coronary artery disease	9.34e-06	0.0403	CbGeAlD
Hydromorphone—CYP2C9—heart—coronary artery disease	7.14e-06	0.0308	CbGeAlD
Hydromorphone—CYP2C9—cardiovascular system—coronary artery disease	6.74e-06	0.0291	CbGeAlD
Hydromorphone—PTGS1—heart—coronary artery disease	6.52e-06	0.0282	CbGeAlD
Hydromorphone—PTGS1—cardiovascular system—coronary artery disease	6.15e-06	0.0266	CbGeAlD
Hydromorphone—PTGS1—cardiac atrium—coronary artery disease	5.58e-06	0.0241	CbGeAlD
Hydromorphone—CYP2C9—blood—coronary artery disease	5.33e-06	0.023	CbGeAlD
Hydromorphone—PTGS1—blood—coronary artery disease	4.87e-06	0.021	CbGeAlD
Hydromorphone—CYP2D6—Metabolism—HBA1—coronary artery disease	4.56e-06	5.23e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LIPC—coronary artery disease	4.56e-06	5.23e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	4.56e-06	5.23e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOC3—coronary artery disease	4.53e-06	5.19e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.52e-06	5.18e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—FGF2—coronary artery disease	4.52e-06	5.18e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GSK3B—coronary artery disease	4.52e-06	5.18e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP2C19—coronary artery disease	4.52e-06	5.18e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LIPC—coronary artery disease	4.52e-06	5.18e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HBA1—coronary artery disease	4.52e-06	5.18e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	4.52e-06	5.18e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HIF1A—coronary artery disease	4.52e-06	5.18e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LDLR—coronary artery disease	4.5e-06	5.16e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AGT—coronary artery disease	4.5e-06	5.16e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOC3—coronary artery disease	4.49e-06	5.15e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AGT—coronary artery disease	4.49e-06	5.14e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—POMC—coronary artery disease	4.48e-06	5.14e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CREB1—coronary artery disease	4.48e-06	5.14e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LDLR—coronary artery disease	4.46e-06	5.12e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.46e-06	5.11e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOS3—coronary artery disease	4.46e-06	5.11e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC9A1—coronary artery disease	4.45e-06	5.1e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTT1—coronary artery disease	4.45e-06	5.1e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GCLM—coronary artery disease	4.41e-06	5.06e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.41e-06	5.06e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTT1—coronary artery disease	4.41e-06	5.06e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC9A1—coronary artery disease	4.41e-06	5.06e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APOE—coronary artery disease	4.41e-06	5.06e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—LEP—coronary artery disease	4.41e-06	5.06e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GCLC—coronary artery disease	4.4e-06	5.04e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CETP—coronary artery disease	4.4e-06	5.04e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—APOE—coronary artery disease	4.4e-06	5.04e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCL2—coronary artery disease	4.39e-06	5.03e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6R—coronary artery disease	4.37e-06	5.01e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GCLC—coronary artery disease	4.36e-06	5e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CETP—coronary artery disease	4.36e-06	5e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APOA1—coronary artery disease	4.36e-06	5e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SDC1—coronary artery disease	4.35e-06	4.99e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—APOA1—coronary artery disease	4.35e-06	4.98e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—JAK2—coronary artery disease	4.33e-06	4.97e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KDR—coronary artery disease	4.32e-06	4.95e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IGF1—coronary artery disease	4.31e-06	4.94e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SDC1—coronary artery disease	4.31e-06	4.94e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK14—coronary artery disease	4.29e-06	4.92e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—MAPK1—coronary artery disease	4.29e-06	4.92e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.27e-06	4.9e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.27e-06	4.9e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PIK3CA—coronary artery disease	4.25e-06	4.87e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—coronary artery disease	4.23e-06	4.84e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ESR1—coronary artery disease	4.21e-06	4.83e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.21e-06	4.83e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.16e-06	4.77e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FN1—coronary artery disease	4.16e-06	4.77e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—F2—coronary artery disease	4.16e-06	4.77e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HADH—coronary artery disease	4.15e-06	4.76e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.15e-06	4.76e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6ST—coronary artery disease	4.14e-06	4.75e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NFKBIA—coronary artery disease	4.11e-06	4.71e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PSMB5—coronary artery disease	4.11e-06	4.71e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PSMA6—coronary artery disease	4.11e-06	4.71e-05	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.1e-06	4.7e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SERPINE1—coronary artery disease	4.1e-06	4.69e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PSMA6—coronary artery disease	4.07e-06	4.67e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PSMB5—coronary artery disease	4.07e-06	4.67e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.07e-06	4.66e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—blood—coronary artery disease	4.06e-06	0.0175	CbGeAlD
Hydromorphone—UGT1A9—Metabolism—NOS3—coronary artery disease	4.04e-06	4.63e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CTGF—coronary artery disease	4.01e-06	4.6e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—blood—coronary artery disease	4e-06	0.0173	CbGeAlD
Hydromorphone—OPRM1—Signaling Pathways—KIT—coronary artery disease	3.98e-06	4.56e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CTGF—coronary artery disease	3.98e-06	4.56e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.98e-06	4.56e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GOT2—coronary artery disease	3.98e-06	4.56e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—FGF2—coronary artery disease	3.97e-06	4.54e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL8—coronary artery disease	3.96e-06	4.53e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GOT2—coronary artery disease	3.94e-06	4.52e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMGCR—coronary artery disease	3.94e-06	4.52e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.93e-06	4.51e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX2—coronary artery disease	3.93e-06	4.51e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOA2—coronary artery disease	3.93e-06	4.51e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOS3—coronary artery disease	3.91e-06	4.48e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.89e-06	4.45e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HK1—coronary artery disease	3.89e-06	4.45e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX4—coronary artery disease	3.89e-06	4.45e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.89e-06	4.45e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HADHA—coronary artery disease	3.84e-06	4.4e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PPARG—coronary artery disease	3.83e-06	4.39e-05	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AKT1—coronary artery disease	3.82e-06	4.38e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GSK3B—coronary artery disease	3.82e-06	4.38e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JAK2—coronary artery disease	3.8e-06	4.36e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.8e-06	4.35e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—POMC—coronary artery disease	3.79e-06	4.34e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CREB1—coronary artery disease	3.79e-06	4.34e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CASP3—coronary artery disease	3.79e-06	4.34e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—POMC—coronary artery disease	3.78e-06	4.33e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—coronary artery disease	3.76e-06	4.31e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LPA—coronary artery disease	3.75e-06	4.3e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CA—coronary artery disease	3.73e-06	4.27e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCL2—coronary artery disease	3.71e-06	4.25e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6R—coronary artery disease	3.7e-06	4.24e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—coronary artery disease	3.7e-06	4.24e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—coronary artery disease	3.69e-06	4.22e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.66e-06	4.19e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF1—coronary artery disease	3.65e-06	4.18e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.63e-06	4.17e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK1—coronary artery disease	3.63e-06	4.16e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.63e-06	4.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOA5—coronary artery disease	3.6e-06	4.12e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MMP9—coronary artery disease	3.58e-06	4.1e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.56e-06	4.08e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.55e-06	4.06e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—P4HB—coronary artery disease	3.53e-06	4.04e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.52e-06	4.03e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	3.47e-06	3.98e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	3.47e-06	3.98e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.47e-06	3.97e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.46e-06	3.97e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	3.46e-06	3.97e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—coronary artery disease	3.44e-06	3.95e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GGT1—coronary artery disease	3.43e-06	3.94e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GOT1—coronary artery disease	3.43e-06	3.94e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GGT1—coronary artery disease	3.4e-06	3.9e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GOT1—coronary artery disease	3.4e-06	3.9e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FGF2—coronary artery disease	3.35e-06	3.84e-05	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	3.35e-06	3.84e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CASP3—coronary artery disease	3.32e-06	3.8e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOS3—coronary artery disease	3.31e-06	3.79e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—coronary artery disease	3.3e-06	3.78e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NOS3—coronary artery disease	3.3e-06	3.78e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—VCAN—coronary artery disease	3.26e-06	3.74e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.24e-06	3.71e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—coronary artery disease	3.23e-06	3.7e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	3.21e-06	3.68e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JAK2—coronary artery disease	3.21e-06	3.68e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	3.15e-06	3.61e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—DCN—coronary artery disease	3.14e-06	3.6e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MMP9—coronary artery disease	3.14e-06	3.6e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.08e-06	3.54e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.06e-06	3.51e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.06e-06	3.5e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.06e-06	3.5e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	3.04e-06	3.49e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.04e-06	3.49e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.03e-06	3.47e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.02e-06	3.46e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—coronary artery disease	3.01e-06	3.45e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CAT—coronary artery disease	3e-06	3.44e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HBA1—coronary artery disease	2.98e-06	3.42e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LIPC—coronary artery disease	2.98e-06	3.42e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.98e-06	3.42e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.98e-06	3.42e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CAT—coronary artery disease	2.98e-06	3.41e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOC3—coronary artery disease	2.96e-06	3.4e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	2.95e-06	3.38e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LDLR—coronary artery disease	2.94e-06	3.37e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	2.93e-06	3.36e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOB—coronary artery disease	2.91e-06	3.34e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.91e-06	3.33e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.91e-06	3.33e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	2.89e-06	3.31e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOB—coronary artery disease	2.89e-06	3.31e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GCLC—coronary artery disease	2.88e-06	3.3e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CETP—coronary artery disease	2.88e-06	3.3e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SDC1—coronary artery disease	2.84e-06	3.26e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.83e-06	3.25e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.83e-06	3.25e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	2.82e-06	3.23e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.81e-06	3.22e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CASP3—coronary artery disease	2.81e-06	3.22e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—coronary artery disease	2.79e-06	3.19e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LPL—coronary artery disease	2.78e-06	3.19e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LPL—coronary artery disease	2.76e-06	3.16e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—coronary artery disease	2.73e-06	3.13e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPX1—coronary artery disease	2.71e-06	3.11e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPX1—coronary artery disease	2.69e-06	3.08e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.69e-06	3.08e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.69e-06	3.08e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP9—coronary artery disease	2.65e-06	3.04e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CD36—coronary artery disease	2.64e-06	3.03e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CTGF—coronary artery disease	2.62e-06	3.01e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CD36—coronary artery disease	2.62e-06	3e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.61e-06	2.99e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.6e-06	2.98e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GOT2—coronary artery disease	2.6e-06	2.98e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.59e-06	2.97e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	2.59e-06	2.96e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	2.57e-06	2.95e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	2.54e-06	2.91e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	2.51e-06	2.88e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.51e-06	2.87e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.48e-06	2.85e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.39e-06	2.74e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	2.38e-06	2.73e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AGT—coronary artery disease	2.38e-06	2.73e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AGT—coronary artery disease	2.36e-06	2.7e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOE—coronary artery disease	2.33e-06	2.67e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.32e-06	2.66e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOE—coronary artery disease	2.31e-06	2.65e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOA1—coronary artery disease	2.31e-06	2.64e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOA1—coronary artery disease	2.29e-06	2.62e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CA—coronary artery disease	2.27e-06	2.61e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GOT1—coronary artery disease	2.25e-06	2.57e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GGT1—coronary artery disease	2.25e-06	2.57e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—coronary artery disease	2.22e-06	2.55e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	2.2e-06	2.52e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.19e-06	2.51e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	2.19e-06	2.5e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	2.14e-06	2.46e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT1—coronary artery disease	2.05e-06	2.35e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARG—coronary artery disease	2.03e-06	2.33e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.02e-06	2.31e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARG—coronary artery disease	2.01e-06	2.31e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—POMC—coronary artery disease	2e-06	2.3e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2e-06	2.29e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.99e-06	2.28e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—POMC—coronary artery disease	1.99e-06	2.28e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CAT—coronary artery disease	1.96e-06	2.25e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—coronary artery disease	1.95e-06	2.23e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOB—coronary artery disease	1.91e-06	2.18e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.86e-06	2.13e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKT1—coronary artery disease	1.86e-06	2.13e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CA—coronary artery disease	1.85e-06	2.12e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.85e-06	2.12e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—coronary artery disease	1.83e-06	2.09e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LPL—coronary artery disease	1.82e-06	2.08e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—coronary artery disease	1.81e-06	2.08e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT1—coronary artery disease	1.8e-06	2.06e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX1—coronary artery disease	1.77e-06	2.03e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NOS3—coronary artery disease	1.75e-06	2e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NOS3—coronary artery disease	1.73e-06	1.99e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CD36—coronary artery disease	1.73e-06	1.98e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.71e-06	1.96e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—coronary artery disease	1.65e-06	1.89e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.64e-06	1.88e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.6e-06	1.83e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.58e-06	1.82e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AGT—coronary artery disease	1.56e-06	1.78e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOE—coronary artery disease	1.52e-06	1.75e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT1—coronary artery disease	1.52e-06	1.74e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKT1—coronary artery disease	1.51e-06	1.74e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOA1—coronary artery disease	1.51e-06	1.73e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARG—coronary artery disease	1.33e-06	1.52e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—POMC—coronary artery disease	1.31e-06	1.5e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—coronary artery disease	1.19e-06	1.37e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NOS3—coronary artery disease	1.14e-06	1.31e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.04e-06	1.2e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	9.83e-07	1.13e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CA—coronary artery disease	9.75e-07	1.12e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKT1—coronary artery disease	8.03e-07	9.21e-06	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKT1—coronary artery disease	7.96e-07	9.13e-06	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.43e-07	7.37e-06	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKT1—coronary artery disease	5.25e-07	6.02e-06	CbGpPWpGaD
